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The synthesis of several sulfates of trichothecene mycotoxins is presented. Deoxynivalenol (DON) and its
acetylated derivatives were synthesized from 3-acetyldeoxynivalenol (3ADON) and used as substrate for
sulfation in order to reach a series of ﬁve different DON-based sulfates as well as T2-toxin-3-sulfate.
These substances are suspected to be formed during phase-II metabolism in plants and humans. The
sulfation was performed using a sulfuryl imidazolium salt, which was synthesized prior to use. All
protected intermediates and ﬁnal products were characterized via NMR and will serve as reference
materials for further investigations in the ﬁelds of toxicology and bioanalytics of mycotoxins.
 2014 The Authors. Published by Elsevier Ltd. All rights reserved.1. Introduction
Deoxynivalenol (DON), its acetylated derivatives, which occur as
3-acetyldeoxynivalenol (3ADON), 15-acetyldeoxynivalenol
(15ADON), and 3,15-diacetyldeoxynivalenol (3,15-diADON) as well
as T2-toxin (Fig. 1) are very common andwidespread trichothecene
mycotoxins. They are predominantly produced by different Fusa-
rium species and can contaminate food and feed. They are known to, and T2-toxin.
he CC BY-NC-ND license
7; fax: þ43 1 58801 15499;
uhmann).
. Published by Elsevier Ltd. All righact as a protein biosynthesis inhibitor,1,2 neurotoxin, immunosup-
pressive or nephrotoxin3 and can cause acute and chronic symp-
toms4 after uptake. Based on this knowledge, regulatory limits
regarding the toxin concentration for food and feed were estab-
lished to minimize the daily uptake.
Although these limits cover the toxins themselves, there is still
a lack of information regarding the occurrence and toxicity of their
conjugated forms. DON, for example, can undergo glycosylation
during late phase-II metabolism in the plant to end up as DON-3-b-
D-O-glucoside, which is classiﬁed as masked mycotoxin.5 A similar
conjugation leads to the corresponding T2-toxin glucoside, which
was recently discovered.6 These masking mechanisms can also lead
to di- and triglycosides, which are difﬁcult to investigate due to
a lack of authentic reference standards. Themain concern regarding
these masked forms is the fact that the occurring conjugates can be
cleaved in the stomach after uptake, whereby releasing the parent
toxin. In addition to the stomach, this cleavage could also occur
within the process of malting,7 leading to an increase of free DON.
Besides the formation of glycosides, other masking processes like
sulfation or thia-michael addition can take place. Zearalenone is
another prominent mycotoxin produced by Fusarium species and
its metabolite zearalenone-14-sulfate8 was previously synthesized9
in order to serve as reference material for contamination andts reserved.
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toxin sulfates10 was recently published showing the emerging re-
search interest within the ﬁeld of mycotoxin sulfur conjugates.
Besides the occurrence of different masked mycotoxins in plants,
many parent toxins also undergo phase-II metabolism in living
organisms, leading mainly to their corresponding glucuronides11
but also to their sulfates.12,13 Besides the occurring glucuronides,
which are accessible14 and were already used for the successful
development of a biomarker method15e17 for human deoxy-
nivalenol exposure estimation, little is known about possible oc-
curring trichothecene sulfates. Considering that sulfate conjugates
are described for different substance classes like
steroids,18 pollutants,19 and drugs,20,21 we assume that there might
be even more trichothecene-derived sulfates occurring during
metabolism.
The objective of this work was the development of a reliable
synthetic strategy for the sulfation of trichothecenes to access all
possible DON-sulfates incorporating their acetylated derivatives and
T2-toxin-3-sulfate. Since the reactivity of the three hydroxyl groups
in deoxynivalenol is somewhat different in the order 15>3>>7
(Fig. 2), we expected all kinds of 3- and 15-sulfates to occur. However,
we were interested in evaluating the possibility to obtain also some
C7-sulfates.Fig. 2. Structural numbering of trichothecenes.3ADON was isolated and crystallized22 from an extract of
Fusarium graminearum andwas directly used after comparisonwith
a 3ADON standard. Deprotection and the following acetylation of
DON23 led us to the four desired structures, which we wanted to
utilize for sulfation (Scheme 1) to access a series of different
sulfates.Scheme 1. Synthetic strategies toward all possible sulfate conjugates. S¼sulfation, D¼deprotection, deAc¼deacetylation.Regarding sulfation itself, numerous synthetic methods24 can be
found within the literature mainly based on the application of
commercially available sulfur trioxide complexes. Since these
methods are limited concerning possible chemical modiﬁcations
after installation of the sulfate group as well as yield,reproducibility, and regioselectivity, several newer protective
groups for the sulfation of organic molecules are described in lit-
erature. Besides the fact that we already made good experiences in
our group regarding the separation of intermediates and yields by
the use of 2,2,2-trichloroethyl (TCE) protective groups25 within
chemical sulfation and glycosylation reactions, the use of this
protective group also offers the possibility of mild deprotection
conditions. The cleavage could therefore be done via catalytic
transfer hydrogenation (Pd/C) or via different mild reductive
methods including ammonium formate or Zn/ammonium formate.
In addition, a verymild protocol using sulfuryl imidazolium salts
was recently employed in the synthesis of trichloroethyl-protected
sulfates on carbohydrates and offered a good possibility of the
sulfation of the fragile trichothecene scaffold.2. Results and discussion
After synthesis of the proper sulfuryl imidazolium salt26
(Scheme 2a, 26), the method evaluation was done by the use of
a simple mimic27 (Scheme 2b, 27), which was selected because of
an incorporated primary alcohol group, a labile acetic ester group
(like T2-toxin), and its UV activity.
The reaction of 26 and 27 to 28 proceeds smoothly if freshly
sublimed dimethylimidazole is used. The deprotection toward 29
was done in an ultrasonic bath at room temperature, which
shortened the reaction time to 20min. This is a crucial achievement
since trichothecenes often own labile ester groups, which are
rapidly cleaved in different solvents. The deprotection toward 30
was done via NaOMe and was carried out as a proof of concept
regarding the deprotection of acetylated sulfates.
The reactions toward the different acetylated DON derivates
(Scheme 3) were carried out as described in literature23 and led to
all desired products.
The sulfation of 1 yielded (as expected) only one product, which
was identiﬁed as the protected 3ADON-15-sulfate, and sulfation of
3 yielded only the protected 15ADON-3-sulfate. Both substances
were successfully deprotected to the free sulfates as ammonium
salt. In case of 4 no reactionwas observed at all, evenwith 4 equiv of
26 and prolonged reaction time (Scheme 4).
In case of 2 we isolated protected DON-3,15-disulfate surpris-
ingly together with DON-3-sulfate instead of the expected 15-sulfate (Scheme 5). Additionally, these two products were the
only ones, which were isolated. In general, we were expecting
position 7 to be somewhat unreactive due to steric hindrance and
poor nucleophilicity. Nevertheless, since acetylation resulted in
a 2:1mixture of the 15- to the 3-product, we also expected a similar
Scheme 2. Synthesis of the protected sulfate donor (A, 26) and method evaluation
with a simple mimic (B, 27). Conditions: (a) pyridine, SO2Cl2, 80 C to rt, 24 h, 97%, (b)
2-methyl imidazole, 2 h, 99%, (c) Et2O, 0 C, MeOTf, 6 h, 94%, (d), 1,2-
dimethylimidazole, 0 C, DCM, 24 h, 82%, (e) MeOH, HCOONH4, Zn, 20 min, 81%, (f)
MeOH, NaOMe, 1 h, 42%.
Scheme 3. Synthesis of different deoxynivalenol derivatives. Conditions: (a) NaOMe,
MeOH, 2 h, 94%, (b) Ac2O, DMAP, 18 h, 47% for 3, 23% for 4, sum¼70%.
Scheme 4. Synthesis of different acetyldeoxynivalenol-derived sulfates. Conditions:
(a) DCM, 2.5 equiv 1,2-dimethylimidazole, 1.25þ0.75 equiv 26, 0 C, 18 h, 52%, (b)
MeOH, 9 equiv HCOONH4, 3 equiv Zn, 20 min, 72%, (c) DCM, 2.7 equiv 1,2-
dimethylimidazole, 1.35 equiv 26, 0 C, 18 h, 34%, (d) MeOH, 9 equiv HCOONH4,
3 equiv Zn, 20 min, 89%.
Scheme 5. Synthesis of DON-3-sulfate and DON-3,15-disulfate as their ammonium
salts. Conditions: (a) DCM, 4 equiv 1,2-dimethylimidazole, 2 equiv 26, 0 C, 18 h, 24%
for 9, 30% for 8, (b) MeOH, 18 equiv HCOONH4, 6 equiv Zn, 2 h, 54%, (c) MeOH, 9 equiv
HCOONH4, 3 equiv Zn, 30 min, 98%.
Scheme 6. Synthesis of DON-15-sulfate as ammonium salt. Conditions: (a) MeOH,
NaOMe, 2 h, 69%.
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itself has not undergone any decomposition (observed via TLC)
during workup, so we could also exclude the theory of degradation
from the disulfate species toward the monosulfate. Deprotection of
both substances yielded DON-3-sulfate as ammonium salt and
DON-3,15-disulfate as the corresponding diammonium salt.
Position 7 was not sulfated during any reaction. Of the
remaining ﬁve theoretically possible sulfates, only DON-15-sulfate
was not isolated after direct sulfation (Scheme 1). For this reason
we used deacetylation of 3ADON-15-sulfate (Scheme 6) to com-
plete the set of sulfates.
Having proven that the method is well working for trichothe-
cenes, we aimed also for the sulfation of T2-toxin, which was car-
ried out in a similar way, whereby leading to the corresponding 3-
sulfate as ammonium salt (Scheme 7).
Finally, all isolated protected intermediates as well as all am-
monium sulfates were characterized via NMR, and 1H shifts were
assigned using several NMR references28,29 for DON and its de-
rivatives. For the assignment of the 1H shifts of T2-toxin-3-sulfate,
COSY and HMBC spectra were recorded. We tried to purify all in-
termediates very quickly over short columns (10e15 g silica), since
we have encountered deacetylation of all types of trichothecenes
during column chromatography (silica as well as RP). Therefore, we
ended up with traces of 1,2-dimethylimidazole within the
Scheme 7. Synthesis of T2-toxin-3-sulfate as ammonium salt. Conditions: (a) DCM,
4 equiv 1,2-dimethylimidazole, 2 equiv 26, 0 C, 18 h, 49%, (b) MeOH, 9 equiv
HCOONH4, 3 equiv Zn, 1 h, 29%.
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chromatography was done with very polar solvents (DCM/MeOH/
NH4OH¼10:4:1 or 10:2.5:0.5), which led to HCOONH4 impurities in
our products. Because of this we usually made a second column
chromatography, followed by lyophilization, and continued drying
for several days to remove remaining HCOONH4. All NMR spectra
and 1H chemical shift assignments can be found in the
Supplementary data.
3. Conclusion
Considering the proven unreactivity of the C7 position to
chemical sulfation, we have synthesized, isolated, and character-
ized all possible DON-sulfates including its acetylated derivatives.
In case of T2-toxin we were also able to synthesize the desired T2-
toxin-3-sulfate. Therefore, we have proven that the utilizedmethod
is well working for trichothecenes and provides a good way to
access the class of trichothecene sulfates via sulfation of the parent
toxins including their acetylated derivatives. Separation of the
protected intermediates was done using column chromatography,
followed by fast deprotection by the use of Zn/HCOONH4 within an
ultrasonic bath. All products and intermediates were characterized
by 1H and 13C NMR, and all 1H chemical shifts were assigned to the
substances. The gathered 1H NMR information will serve as
a valuable reference for naturally isolated material. Finally, all
standards will be used for identiﬁcation and quantiﬁcation of their
occurrence and formation within human and plant metabolism.
4. Experimental section
4.1. General remarks
CAUTION: All used toxins are strong protein biosynthesis in-
hibitors and can cause a series of acute and chronic symptoms.
Therefore, we strongly recommend considering their toxicity
within all reactions!
All reactions were carried out under an argon atmosphere and
the progress of all reactions was monitored using thin-layer chro-
matography (TLC) over silica gel 60F254 (Merck, Germany). All
chromatograms were visualized by heat staining using ceric am-
monium molybdate/Hanessian’s stain30 in ethanol/sulfuric acid.
Chromatographic separation was done on silica gel 60 (40e63 mm)
using a SepacoreTM Flash System (B€uchi, Switzerland) or glass
columns. All samples were measured via LCeESI-MS/MS and
LCeAPCI-MS/MS and in a negative ionization mode. These mea-
surements were performed on an HCT ion trap mass spectrometer
(Bruker, Germany). A TLCeMS interface (Camag, Germany) was
used for ESI-MS analysis after TLC. 1H and 13C spectrawere recorded
upon using a Bruker DPX-200 spectrometer as well as an Avance
DRX-400 MHz spectrometer (both Bruker, Germany). Data wererecorded and evaluated using TOPSPIN 1.3 (Bruker Biospin). All
chemical shifts are given in parts per million relative to tetrame-
thylsilane. The calibration was done using residual solvent
signals.31 Multiplicities are abbreviated as s (singlet), d (doublet), t
(triplet), q (quartet), and br (broad signal). 3-ADON was obtained
from BOKU, Dept. for Agrarbiotechnology (IFA-Tulln) as crude fer-
mentation extract, puriﬁed via column chromatography, and used
after the 1H NMR purity check. All other chemicals were purchased
from ABCR (Germany) and SigmaeAldrich (Austria/Germany).
4.2. 2,2,2-Trichloroethyl 2-(4-acetoxyphenyl)ethylsulfate (28)
Compound 27 (121.8 mg, 0.68 mmol, 1.0 equiv) was dissolved in
3 mL DCM and a solution of 1,2-dimethylimidazole (194.9 mg,
2.03 mmol, 3.0 equiv) in 1 mL DCM was added at 0 C. Then, 26
(464.0 mg, 1.01 mmol, 1.5 equiv) was added in one portion and the
reaction was allowed to warm to room temperature over night.
After TLC indicated full conversion the reaction was directly puri-
ﬁed via column chromatography (hexane/EtOAc¼1:1) to yield 28
(215.8 mg, 82%) as white solid. 1H NMR (200 MHz, CDCl3) d 7.28 (s,
4H), 4.82 (s, 2H), 4.27 (t, J¼6.8 Hz, 2H), 2.95 (t, J¼6.8 Hz, 2H), 2.02 (s,
3H); 13C NMR (50 MHz, CDCl3) d 171.0 (s, 1C), 148.9 (s, 1C), 138.1 (s,
1C), 130.6 (d, 2C), 121.2 (d, 2C), 92.5 (s, 1C), 80.5 (t, 1C), 64.5 (t, 1C),
34.5 (t, 1C), 21.0 (q, 1C). HRMS m/z calcd for C12H14O6SCl3
þ
[MþH]þ, 390.9571, found 390.9578.
4.3. 2-(4-Acetoxyphenyl)ethylsulfate, ammonium salt (29)
Compound 28 (190.0 mg, 0.49 mmol, 1.0 equiv) was dissolved in
5 mL MeOH. Ammonium formate (276.5 mg, 4.39 mmol, 9.0 equiv)
and Zn dust (95.6 mg, 1.46 mmol, 3.0 equiv) were added and the
reaction was placed in an ultrasonic bath. After 20 min, TLC
revealed complete conversion of the starting material and the re-
action mixture was ﬁltered through Celite and concentrated to
1 mL. Direct puriﬁcation of this solution using column chroma-
tography (DCM/MeOH/NH4OH¼10:2.5:0.5) yielded 29 (109.5 mg,
81%) as white solid. 1H NMR (200 MHz, methanol-d4) d¼7.22 (br,
4H), 4.93 (br, NH4
þ; H2O), 4.23 (t, J¼6.9 Hz, 2H), 2.91 (t, J¼6.9 Hz,
2H), 2.00 (s, 3H); 13C NMR (50 MHz, methanol-d4) d 172.9 (s, 1C),
152.5 (s, 1C), 136.0 (s, 1C), 130.6 (d, 2C), 122.5 (d, 2C), 66.2 (t, 1C),
35.3 (t, 1C), 20.8 (q, 1C). HRMSm/z calcd for C10H11O6S [MNH4],
259.0282, found 259.0278.
4.4. 2-(4-Hydroxyphenyl)ethylsulfate, ammonium salt (30)
Compound 29 (69.0 mg, 0.25 mmol, 1.00 equiv) was dissolved in
2 mL dry MeOH and NaOMe (14.1 mg, 0.26 mmol, 1.05 equiv) was
added. Since no reaction occurred after 30 min we added the same
amount of NaOMe again. After stirring for 30min, TLC indicated full
conversion and the reaction was directly puriﬁed via column
chromatography (DCM/MeOH/NH4OH¼10:2.5:0.5) to yield 9
(28.7 mg, 42%) as white solid. 1H NMR (200 MHz, methanol-d4)
d¼7.21 (s, 4H), 4.90 (br, NH4þ; H2O), 3.73 (t, J¼6.9 Hz, 2H), 2.80 (t,
J¼6.9 Hz, 2H); 13C NMR (50 MHz, methanol-d4) d 152.3 (s, 1C), 137.0
(s, 1C), 130.6 (d, 2C), 122.5 (d, 2C), 64.2 (t, 1C), 39.5 (t, 1C). HRMSm/z
calcd for C8H9O5S ½M NH4þ; 217.0176, found 217.0174.
4.5. 15-ADON (3) and 3,15-diADON (4)
3-ADON (1) (95.6 mg, 0.28 mmol, 1.0 equiv) was dissolved in
5 mL methanol, followed by the addition of NaOMe (13.7 mg,
0.25 mmol, 0.9 equiv). After 2 h, TLC showed full conversion of the
1. The reaction was concentrated to 1 mL and directly puriﬁed by
the use of column chromatography (CHCl3/MeOH¼9:1), which
yielded deoxynivalenol (2, 79.0 mg, 94%) as white solid. The re-
action product was proven to be identical to an authentic sample by
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(79.0 mg, 0.27 mmol) was dissolved in 50 mL dry dichloromethane.
Pyridine (1 mL) and 4-DMAP (app. 10 mg) were added, followed by
the dropwise addition of acetic anhydride (27.2 mg, 0.27 mmol).
The reactionwas stirred over night, treatedwith 20mL 2 NHCl, and
extracted with dichloromethane. After drying with Na2SO4, ﬁltra-
tion, and evaporation of the solvent, the remaining residue was
subjected to column chromatography (CHCl3/MeOH¼95:5) to yield
3 (42.0 mg, 47%) and 4 (23.5 mg, 23%) as white solid. Total
yield¼70%, 93% conversion. 15-ADON (3): 1H NMR (200 MHz,
CDCl3) d 6.61 (dq, J¼5.7, 1.6 Hz, 1H), 4.89 (d, J¼5.7 Hz, 1H), 4.83 (d,
J¼1.6 Hz, 1H), 4.52 (dt, J¼10.2, 4.7 Hz, 1H), 4.24 (s, 2H), 3.78 (d,
J¼1.8 Hz, 1H), 3.63 (d, J¼4.5 Hz, 1H), 3.13 (d, J¼4.3 Hz, 1H), 3.08 (d,
J¼4.3 Hz, 1H), 2.22 (dd, J¼14.8, 4.7 Hz, 1H), 2.08 (dd, J¼14.7, 10.4 Hz,
1H), 1.88 (s, 3H), 1.87 (s, 3H), 1.07 (s, 3H); 13C NMR (50 MHz, CDCl3)
d¼199.6 (s), 170.3 (s), 138.8 (d), 135.6 (s), 80.7 (d), 73.5 (d), 70.1 (d),
68.9 (s), 65.5 (s), 62.2 (t), 51.4 (s), 47.4 (t), 46.3 (s), 43.3 (t), 20.7 (q),
15.4 (q), 13.8 (q). 3,15-diADON (4): 1H NMR (200MHz, CDCl3) d 6.56
(dq, J¼5.8, 1.4 Hz,1H), 5.20 (dt, J¼10.9, 4.6 Hz,1H), 4.80 (d, J¼2.0 Hz,
1H), 4.69 (d, J¼5.8 Hz, 1H), 4.27 (d, J¼12.1 Hz, 1H), 4.20 (d,
J¼12.1 Hz, 1H), 3.89 (d, J¼4.3 Hz, 1H), 3.80 (d, J¼2.0 Hz, 1H), 3.14 (d,
J¼4.3 Hz, 1H), 3.09 (d, J¼4.3 Hz, 1H), 2.31 (dd, J¼15.2, 4.8 Hz, 1H),
2.15 (dd, J¼15.2, 10.9 Hz, 1H), 2.12 (s, 3H), 1.88 (s, 3H), 1.87 (s, 3H),
1.08 (s, 3H); 13C NMR (50MHz, CDCl3) d 199.3 (s), 170.3 (s), 170.2 (s),
138.4 (d), 135.6 (s), 78.9 (d), 73.4 (d), 71.1 (d), 70.1 (d), 64.9 (s), 62.1
(t), 51.5 (s), 47.4 (t), 45.8 (s), 40.3 (t), 21.0 (q), 20.6 (q), 15.3 (q), 13.6
(q).
4.6. 2,2,2-Trichloroethyl 3-acetyl-DON-15-sulfate (6)
Compound 1 (45.1 mg, 133 mmol, 1.0 equiv) was dissolved in
2.5 mL of DCM and cooled to 0 C and 1,2-dimethylimidazole
(32.0 mg, 333 mmol, 2.5 equiv) in 1 mL DCM was added to the re-
action. Then, 26 (76.2 mg, 167 mmol, 1.25 equiv) was added and the
reaction was allowed to reach room temperature over night. Since
TLC showed remaining starting material after 18 h, the reactionwas
cooled again to 0 C and another 0.75 equiv of 26 (45.7 mg,
100 mmol) were added. After another 48 h, TLC showed still starting
material, but also the formation of substantial amounts of product.
The reaction was directly used for column chromatography (CHCl3/
MeOH¼95:5), yielding 6 (37.8 mg, 52%) as white solid. 1H NMR
(200MHz, CDCl3) d 6.66 (dq, J¼5.9, 1.4 Hz, 1H), 5.24 (ddd, J¼9.5, 6.0,
4.5 Hz, 1H), 4.89 (d, J¼1.4 Hz, 1H), 4.80 (d, J¼5.9 Hz, 1H), 4.64 (d,
J¼10.8 Hz, 1H), 4.57 (d, J¼10.8 Hz, 1H), 4.56 (d, J¼10.6 Hz, 1H), 4.43
(d, J¼10.6 Hz, 1H), 3.95 (d, J¼4.5 Hz, 1H), 3.84 (d, J¼1.4 Hz, 1H), 3.16
(d, J¼4.1 Hz, 1H), 3.13 (d, J¼4.1 Hz, 1H), 2.10e2.36 (m, 2H), 2.16 (s,
3H), 1.91 (br, 3H), 1.11 (s, 3H); 13C NMR (50 MHz, CDCl3) d 198.8 (s,
1C), 170.2 (s, 1C), 138.7 (d, 1C), 136.1 (s, 1C), 92.4 (s, 1C), 79.7 (t, 1C),
78.8 (d, 1C), 73.0 (d, 1C), 71.6 (t, 1C), 70.7 (d, 1C), 69.1 (d, 1C), 64.6 (s,
1C), 51.3 (s, 1C), 47.4 (t, 1C), 45.8 (s, 1C), 40.4 (t, 1C), 20.9 (q, 1C), 15.2
(q, 1C), 13.5 (q, 1C); HRMS m/z calcd for C19H24O10SCl3
þ [MþH]þ,
549.0150, found 549.0160.
4.7. 2,2,2-Trichloroethyl 15-acetyl-DON-3-sulfate (11)
Compound 3 (76.5 mg, 226 mmol, 1.0 equiv) was dissolved in
3 mL of DCM and cooled to 0 C and 1,2-dimethylimidazole
(58.7 mg, 610 mmol, 2.7 equiv) in 1 mL DCM was added to re-
action. Then 26 (139.7 mg, 305 mmol, 1.35 equiv) was added and the
reaction was allowed to reach room temperature over night. TLC
showed substantial amounts of product and the reaction was di-
rectly used for column chromatography (DCM/MeOH¼95:5)
yielding 11 (42.6 mg, 34%) as white solid. 1H NMR (200MHz, CDCl3)
d 6.60 (dq, J¼5.8,1.5 Hz,1H), 5.31 (dt, J¼11.1, 4.3 Hz,1H), 4.81 (s,1H),
4.79 (s, 2H), 4.70 (d, J¼5.8 Hz, 1H), 4.27 (d, J¼12.1 Hz, 1H), 4.18 (d,
J¼12.1 Hz, 1H), 4.00 (d, J¼4.3 Hz, 1H), 3.71 (s, 1H), 3.21 (d, J¼4.1 Hz,1H), 3.15 (d, J¼4.1 Hz, 1H), 2.64 (dd, J¼15.7, 4.3 Hz, 1H), 2.29 (dd,
J¼15.7, 11.1 Hz, 1H), 1.93 (s, 3H), 1.91 (br, 3H), 1.12 (s, 3H); 13C NMR
(50 MHz, CDCl3) d 198.9 (s, 1C), 170.2 (s, 1C), 137.9 (d, 1C), 136.1 (s,
1C), 92.7 (s, 1C), 80.4 (d, 1C), 80.0 (t, 1C), 78.9 (d, 1C), 73.5 (d, 1C),
70.1 (d, 1C), 64.5 (s, 1C), 62.0 (t, 1C), 51.2 (s, 1C), 47.4 (t, 1C), 46.1 (s,
1C), 40.2 (t, 1C), 20.8 (q, 1C), 15.4 (q, 1C), 13.7 (q, 1C); HRMS m/z
calcd for C19H24O10SCl3
þ [MþH]þ, 549.0150, found 549.0146.
4.8. 2,2,2-Trichloroethyl DON-3-sulfate (8) and bis(2,2,2-
trichloroethyl) DON-3,15-disulfate (9)
Compound 2 (40.6 mg, 137 mmol, 1.0 equiv) was dissolved in
5 mL of DCM and cooled to 0 C and 1,2-dimethylimidazole
(52.7 mg, 548 mmol, 4.0 equiv) in 1 mL DCM was added to the re-
action. Then, 26 (125.4 mg, 274 mmol, 2.0 equiv) was added and the
reaction was allowed to reach room temperature over night. TLC
after 24 h showed nearly full conversion of the starting material
and the reaction was directly used for column chromatography
(DCM/MeOH gradient from 100:0/95:5), yielding 8 (22.4mg, 30%)
and 9 (23.9 mg, 24%) as white solid. 1H NMR of 8 (200 MHz, CDCl3)
d 6.62 (dq, J¼5.9, 1.4 Hz, 1H), 5.31 (dt, J¼11.2, 4.4 Hz, 1H), 4.81 (s,
1H), 4.78 (s, 2H), 4.74 (d, J¼5.9 Hz, 1H), 3.99 (d, J¼4.5 Hz, 1H), 3.86
(d, J¼11.5 Hz, 1H), 3.77 (br, 1H), 3.76 (d, J¼11.5 Hz, 1H), 3.22 (d,
J¼4.1 Hz, 1H), 3.14 (d, J¼4.1 Hz, 1H), 2.80 (dd, J¼15.7, 4.3 Hz, 1H),
2.25 (dd, J¼15.7, 11.2 Hz, 1H), 1.91 (br, 3H), 1.71 (br, 1H), 1.17 (s, 3H);
13C NMR of 8 (50 MHz, CDCl3) d 199.6 (s, 1C), 138.0 (d, 1C), 136.3 (s,
1C), 92.7 (s, 1C, eCCl3 tiny signal!), 80.8 (d, 1C), 79.9 (t, 1C), 79.1 (d,
1C), 74.5 (d, 1C), 70.1 (d, 1C), 64.8 (s, 1C), 62.0 (t, 1C), 51.8 (s, 1C), 47.7
(t, 1C), 46.1 (s, 1C), 40.3 (t, 1C), 15.4 (q, 1C), 14.1 (q, 1C); HRMS m/z
calcd for C17H20O9SCl3
 [MHþ], 504.9899, found 504.9878. 1H
NMR of 9 (200 MHz, CDCl3) d 6.69 (dq, J¼5.9, 1.5 Hz, 1H), 5.32 (dt,
J¼11.1, 4.4 Hz, 1H), 4.88 (s, 1H), 4.81 (dt, J¼5.7, 1.5 Hz, 1H), 4.79 (s,
2H), 4.66 (d, J¼11.0 Hz,1H), 4.60 (d, J¼11.0 Hz,1H), 4.48 (s, 2H), 4.04
(d, J¼4.4 Hz, 1H), 3.83 (br, 1H), 3.21 (d, J¼4.1 Hz, 1H), 3.17 (d,
J¼4.1 Hz, 1H), 2.57 (dd, J¼15.7, 4.2 Hz, 1H), 2.33 (dd, J¼15.7, 11.1 Hz,
1H), 1.93 (br, 3H), 1.15 (s, 3H); 13C NMR of 9 (50 MHz, CDCl3) d 198.5
(s, 1C), 138.2 (d, 1C), 136.6 (s, 1C), 280.0 (d, 1C/t, 1C), 79.9 (t, 1C),
78.9 (d, 1C), 73.3 (d, 1C), 71.5 (t, 1C), 69.2 (d, 1C), 64.3 (s, 1C), 51.3 (s,
1C), 47.7 (t, 1C), 46.2 (s, 1C), 40.3 (t, 1C), 15.3 (q, 1C), 13.6 (q, 1C), 2
CCl3 between 92 and 93 ppm are missing, but the corresponding
CH2 groups are located at 80.0 and 79.9; HRMS m/z calcd for
C17H20O12S2Cl3
 [MTCE], 584.9467, found 584.9505.
4.9. General deprotection procedure
The protected intermediate was dissolved in MeOH (1 mL/
10 mmol starting material). HCOONH4 (3 equiv) as well as Zn dust
(9 equiv) were added and the reaction was placed in an ultrasonic
bath at room temperature. The reaction was followed via TLC until
substantial amounts of products were formed (20e90 min). After
ﬁltration through Celite the remaining residue was subjected to
column chromatography to end up with the corresponding sulfates
as ammonium salts. For all acetylated DON derivatives and T2-
toxin, DCM/MeOH/NH4OH¼10:2.5:0.5 was used for puriﬁcation.
In case of DON-3- and 15-sulfate and 3,15-disulfate, a mixture of
DCM/MeOH/NH4OH¼10:4:1 was used. Since all products contained
accompanying HCOOHNH4, we tried to purify some products via
a second and third column chromatography as well as via lyophi-
lization. Nevertheless, we obtained all desired products as a white
misty veil.
4.10. 3-Acetyl-DON-15-sulfate, ammonium salt (13)
Following the general deprotection procedure, 6 (34.0 mg,
62 mmol) was converted into 13 (19.3 mg, 72%). 1H NMR (200 MHz,
methanol-d4) d 6.63 (dq, J¼6.1, 1.4 Hz, 1H), 5.11 (dt, J¼11.3, 4.4 Hz,
P. Fruhmann et al. / Tetrahedron 70 (2014) 5260e5266 52651H), 4.92 (d, J¼6.1 Hz, 1H), 4.89 (s, 1H), 4,87 (br, NH4þ; H2O), 4.27
(d, J¼11.0 Hz, 1H), 3.94 (d, J¼11.1 Hz, 1H), 3.85 (d, J¼4.5 Hz, 1H), 3.16
(d, J¼4.3 Hz,1H), 3.12 (d, J¼4.3 Hz, 1H), 2.79 (dd, J¼15.3, 4.3 Hz,1H),
2.08 (dd, J¼15.3, 11.3 Hz, 1H), 2.13 (s, 3H), 1.85 (br, 3H), 1.18 (s, 3H);
13C NMR (50 MHz, methanol-d4) d 201.0 (s, 1C), 172.5 (s, 1C), 139.4
(d,1C),137.1 (s,1C), 80.5 (d,1C), 75.8 (d,1C), 72.7 (d,1C), 70.7 (d,1C),
67.1 (t, 1C), 66.3 (s, 1C), 52.3 (s, 1C), 48.4 (t, 1C), 46.8 (s, 1C), 41.7 (t,
1C), 20.8 (q, 1C), 15.3 (q, 1C), 14.4 (q, 1C); HRMS m/z calcd for
C17H21O10S ½M NH4þ; 417.0861, found 417.0834.
4.11. 15-Acetyl-DON-3-sulfate, ammonium salt (18)
Following the general deprotection procedure, 11 (13.1 mg,
24 mmol) was converted into 18 (9.2 mg, 89%). 1H NMR (400 MHz,
methanol-d4) d 6.65 (dq, J¼5.9, 1.5 Hz, 1H), 4.70e5.10 (m, NH4þ;
C3eH, C7eH, C11eH, H2O), 4.30 (d, J¼12.1 Hz, 1H), 4.23 (d,
J¼12.1 Hz, 1H), 3.82 (d, J¼4.5 Hz, 1H), 3.12 (s, 2H), 2.63 (dd, J¼15.3,
4.3 Hz, 1H), 2.11 (dd, J¼15.3, 11.2 Hz, 1H), 1.90 (s, 3H), 1.85 (br, 3H),
1.11 (s, 3H); 13C NMR (100 MHz, methanol-d4) d 201.1 (s, 1C), 171.9
(s, 1C), 139.7 (d, 1C), 137.0 (s, 1C), 81.2 (d, 1C), 75.2 (d, 1C), 75.0 (d,
1C), 71.3 (d, 1C), 65.9 (s, 1C), 63.3 (t, 1C), 52.6 (s, 1C), 48.2 (t, 1C), 47.0
(s, 1C), 42.5 (t, 1C), 20.6 (q, 1C), 15.4 (q, 1C), 14.4 (q, 1C); HRMS m/z
calcd for C17H21O10S ½M NH4þ; 417.0861, found 417.0824.
4.12. DON-3-sulfate, ammonium salt (15)
Following the general deprotection procedure, 8 (18.8 mg,
37 mmol) was converted into 15 (14.3 mg, 98%). 1H NMR (400 MHz,
methanol-d4) d 6.61 (dq, J¼6.1, 1.4 Hz, 1H), 4.75e4.95 (m, NH4þ;
C3eH, C11eH, H2O), 4.79 (s, 1H), 3.80 (d, J¼4.4 Hz, 1H), 3.78 (d,
J¼12.3 Hz, 1H), 3.68 (d, J¼12.3 Hz, 1H), 3.12 (d, J¼4.5 Hz, 1H), 3.09
(d, J¼4.5 Hz, 1H), 2.75 (dd, J¼15.2, 4.4 Hz, 1H), 2.06 (dd, J¼15.2,
11.4 Hz, 1H), 1.83 (br, 3H), 1.12 (s, 3H); 13C NMR (100 MHz, meth-
anol-d4) d 201.7 (s, 1C), 139.4 (d, 1C), 137.0 (s, 1C), 81.2 (d, 1C), 75.8
(d, 1C), 75.4 (d, 1C), 71.6 (d, 1C), 66.3 (s, 1C), 61.8 (t, 1C), 53.6 (s, 1C),
48.2 (t, 1C), 46.7 (s, 1C), 42.5 (t, 1C), 15.4 (q, 1C), 14.6 (q, 1C); HRMS
m/z calcd for C15H19O9S ½M NH4þ; 375.0755, found 375.0741.
4.13. DON-15-sulfate, ammonium salt (14)
Compound 13 (12.0 mg, 28 mmol, 1.0 equiv) was dissolved in
5 mL MeOH and NaOMe (3.0 mg, 55 mmol, 2.0 equiv) was added.
After stirring for 2 h, TLC indicated full conversion of the starting
material and the reactionwas subjected to column chromatography
(DCM/MeOH/NH4OH¼10:4:1), yielding 14 (7.5 mg, 69%) as white
solid. 1H NMR (200 MHz, methanol-d4) d 6.65 (dq, J¼6.1, 1.4 Hz, 1H),
5.04 (d, J¼6.1 Hz, 1H), 4.85e4.95 (m, NH4þ; C7eH, H2O), 4.76 (dt,
J¼11.1, 4.5 Hz, 1H), 4.25 (d, J¼11.0 Hz, 1H), 3.96 (d, J¼11.0 Hz, 1H),
3.55 (d, J¼4.5 Hz, 1H), 3.12 (d, J¼4.5 Hz, 1H), 3.06 (d, J¼4.5 Hz, 1H),
2.57 (dd, J¼14.8, 4.4 Hz, 1H), 1.99 (dd, J¼14.8, 11.1 Hz, 1H), 1.84 (br,
3H), 1.14 (s, 3H); 13C NMR (50 MHz, methanol-d4) d 201.1 (s, 1C),
139.9 (d, 1C), 136.9 (s, 1C), 82.3 (d, 1C), 75.9 (d, 1C), 70.7 (d, 1C), 69.6
(d, 1C), 67.2 (s, 1C), 66.7 (t, 1C), 52.5 (s, 1C), 48.2 (t, 1C), 47.5 (s, 1C),
45.0 (t, 1C), 15.3 (q, 1C), 14.4 (q, 1C); HRMSm/z calcd for C15H19O9S
½M NH4þ; 375.0755, found 375.0746.
4.14. DON-3,15-disulfate, diammonium salt (16)
Following the general deprotection procedure, twice the
amount of HCOONH4 (6 equiv) and Zn dust (18 equiv) were used to
convert 9 (20.0 mg, 28 mmol) into 16 (7.4 mg, 54%). 1H NMR
(400 MHz, methanol-d4) d 6.67 (dq, J¼6.0, 1.5 Hz, 1H), 4.80e5.00
(m, NH4
þ; C3eH, C7eH, C11eH, H2O), 4.24 (d, J¼10.9 Hz, 1H), 3.98
(d, J¼10.9 Hz, 1H), 3.84 (d, J¼4.5 Hz, 1H), 3.15 (d, J¼4.3 Hz, 1H), 3.10
(d, J¼4.3 Hz, 1H), 2.97 (dd, J¼15.3, 4.5 Hz, 1H), 2.10 (dd, J¼15.3,
11.4 Hz, 1H), 1.85 (br, 3H), 1.16 (s, 3H); 13C NMR (100 MHz,methanol-d4) d 201.3 (s, 1C), 139.6 (d, 1C), 137.2 (s, 1C), 81.3 (d, 1C),
75.8 (d, 1C), 75.7 (d, 1C), 70.5 (d, 1C), 67.4 (s, 1C), 66.1 (t, 1C), 52.4 (s,
1C), 48.4 (t, 1C), 47.1 (s, 1C), 42.4 (t, 1C), 15.3 (q, 1C), 14.5 (q, 1C);
HRMS m/z calcd for C15H20O12S2
 ½M 2 NH4þ þ Hþ;
455.0323, found 455.0300.
4.15. 2,2,2-Trichloroethyl T2-toxin-3-sulfate (21)
Compound 5 (37.4 mg, 80 mmol, 1.0 equiv) was dissolved in 3 mL
of DCM, cooled to 0 C, and 1,2-dimethylimidazole (30.8 mg,
321 mmol, 4.0 equiv) in 1 mL DCMwas added to the reaction. Then,
26 (73.4 mg,160mmol, 2.00 equiv) was added and the reactionwas
allowed to reach room temperature over night. After 18 h, TLC
showed substantial amounts of product and the reaction was di-
rectly used for column chromatography (DCM/MeOH¼95:5),
yielding 21 (26.4 mg, 49%) as white solid. 1H NMR (200MHz, CDCl3)
d 6.16 (d, J¼3.1 Hz, 1H), 5.77 (dt, J¼5.7, 1.4 Hz, 1H), 5.28 (d, J¼5.5 Hz,
1H), 5.10 (dd, J¼4.9, 3.1 Hz, 1H), 4.80 (s, 2H), 4.31 (d, J¼12.7 Hz, 1H),
4.25 (d, J¼5.7 Hz, 1H), 4.10 (d, J¼12.7 Hz, 1H), 3.96 (d, J¼4.9 Hz, 1H),
3.09 (d, J¼3.9 Hz,1H), 2.85 (d, J¼3.9 Hz,1H), 2.35 (dd, J¼15.2, 6.0 Hz,
1H), 2.11 (s, 3H), 2.09 (s, 3H), 2.00e2.25 (m, 3H), 1.80 (d, J¼16.6 Hz,
1H), 1.76 (s, 3H), 0.96 (d, J¼6.3 Hz, 3H), 0.95 (d, J¼6.3 Hz, 3H), 0.74
(s, 3H); 13C NMR (50 MHz, CDCl3) d 172.8 (s, 1C), 170.4 (s, 1C), 170.2
(s, 1C), 137.1 (s, 1C), 123.0 (d, 1C), 92.6 (s, 1C), 87.1 (d, 1C), 80.1 (t, 1C),
78.4 (d, 1C), 77.4 (d, 1C), 67.7 (d, 1C), 67.5 (d, 1C), 64.6 (t, 1C), 63.8 (s,
1C), 48.7 and 47.5 (1t, 1s, 2 1C), 43.7 (t, 1C), 43.1 (s, 1C), 28.4 (t, 1C),
25.9 (d,1C), 22.6 (q,1C), 22.5 (q,1C), 21.2 (q,1C), 20.8 (q,1C), 20.4 (q,
1C), 6.5 (q, 1C); HRMS m/z calcd for C24H33O12S [MTCE-group],
545.1698, found 545.1679.
4.16. T2-toxin-3-sulfate, ammonium salt (22)
Following the general deprotection procedure, 21 (20.8 mg,
31 mmol) was converted into 22 (5.0 mg, 29%). 1H NMR (400 MHz,
methanol-d4) d 6.03 (d, J¼3.1 Hz, 1H), 5.78 (dt, J¼5.5 Hz, 1H), 5.33
(d, J¼5.5 Hz, 1H), 4.80e4.94 (m, NH4þ; C3eH, H2O), 4.33 (d,
J¼12.1 Hz,1H), 4.32 (d, J¼5.5 Hz,1H), 4.16 (d, J¼12.1 Hz,1H), 3.79 (d,
J¼5.1 Hz, 1H), 3.04 (d, J¼3.9 Hz, 1H), 2.87 (d, J¼3.9 Hz, 1H), 2.38 (dd,
J¼15.3, 5.5 Hz, 1H), 2.13e2.18 (m, 2H), 2.07 (s, 3H), 2.06 (s, 3H),
2.00e2.12 (m, 1H), 1.92 (d, J¼15.3 Hz, 1H), 1.74 (s, 3H), 0.97 (d,
J¼6.7 Hz, 3H), 0.96 (d, J¼6.7 Hz, 3H), 0.72 (s, 3H); 13C NMR
(100 MHz, methanol-d4) d 174.0 (s, 1C), 172.3 (s, 1C), 172.2 (s, 1C),
137.2 (s, 1C), 125.1 (d, 1C), 82.3 (d, 1C), 81.5 (d, 1C), 79.7 (d, 1C), 69.4
(d, 1C), 68.5 (d, 1C), 65.8 (t, 1C), 65.0 (s, 1C), 50.1 and 47.8 (1t, 1s, 2
1C), 44.5 (t, 1C), 44.3 (s, 1C), 28.8 (t, 1C), 26.9 (d, 1C), 22.8 (q, 1C),
22.7 (q, 1C), 21.3 (q, 1C), 20.7 (q, 1C), 20.4 (q, 1C), 6.9 (q, 1C);
HRMS m/z calcd for C24H33O12S ½M NH4þ; 545.1698, found
545.1682.
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